Literature DB >> 2018998

Neuropeptide Y potentiates specifically the purinergic component of the neural responses in the guinea pig saphenous artery.

D W Cheung1.   

Abstract

Contraction of the guinea pig saphenous artery induced by stimulation of perivascular nerves consists of an adrenergic and a purinergic component. Neuropeptide Y (NPY) potentiated the neural responses significantly at low stimulation frequencies but not at high frequencies when the contraction was maximal. After blocking the adrenoceptors with phentolamine, significant potentiation of the purinergic component by NPY could be demonstrated. The potentiating effect of NPY was abolished in the presence of nifedipine. After desensitizing the purinoceptors with alpha,beta-methylene-ATP, there was no potentiation of the remaining adrenergic component by NPY. NPY also has no effect on contractions induced by exogenous norepinephrine but potentiates those induced by alpha,beta-methylene-ATP. These results suggest that NPY potentiates neurally induced contraction in the guinea pig saphenous artery by a specific action on the purinergic response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018998     DOI: 10.1161/01.res.68.5.1401

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  ATP-Dependent inhibition of Ca2+-activated K+ channels in vascular smooth muscle cells by neuropeptide Y.

Authors:  Z Xiong; D W Cheung
Journal:  Pflugers Arch       Date:  1995-11       Impact factor: 3.657

2.  P2 purinoceptor-mediated control of rat cerebral (pial) microvasculature; contribution of P2X and P2Y receptors.

Authors:  C J Lewis; S J Ennion; R J Evans
Journal:  J Physiol       Date:  2000-09-01       Impact factor: 5.182

3.  Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U)receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors.

Authors:  L A Selbie; N V King; J M Dickenson; S J Hill
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

4.  Neuropeptide Y modulates ATP-induced increases in internal calcium via the adenylate cyclase/protein kinase A system in a human neuroblastoma cell line.

Authors:  V Soares Lemos; B Bucher; K Takeda
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

5.  Effect of neuropeptide Y on adrenergic and non-adrenergic, non-cholinergic responses in the rat anococcygeus muscle.

Authors:  E Vila; A Tabernero; F Fernandes; M Salaices
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

6.  Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells.

Authors:  Z Xiong; B J Bolzon; D W Cheung
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

7.  Neuropeptide Y inhibits Ca(2+)-activated K+ channels in vascular smooth muscle cells from the rat tail artery.

Authors:  Z Xiong; D W Cheung
Journal:  Pflugers Arch       Date:  1994-12       Impact factor: 3.657

8.  Modulatory effects of endothelin-1 on purinergic and adrenergic components of sympathetically-mediated contractile activity of rabbit saphenous artery.

Authors:  V N Mutafova-Yambolieva; R G Radomirov
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

9.  Mechanisms of electrical vasoconstriction.

Authors:  Mark Brinton; Yossi Mandel; Ira Schachar; Daniel Palanker
Journal:  J Neuroeng Rehabil       Date:  2018-05-29       Impact factor: 4.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.